Job Trends
Rampart Bioscience was working on a platform to deliver gene therapies without the need for viral vectors.
Labor Market Reports
BioSpace’s Q3 2025 U.S. Life Sciences Job Market Report reveals a turbulent quarter for biopharma hiring, with record declines in job postings, rising layoffs, and cautious employer sentiment shaping the industry’s employment landscape.
BioSpace data show biopharma professionals faced increased competition for fewer employment opportunities during the second quarter of 2025, with increased pressure from further layoffs.
Establishing trust through thought leadership is no longer optional in today’s cautious biopharma market. Learn how strategic insights and targeted outreach can turn awareness into high-converting leads.
Now Hiring
Looking for a new opportunity in New Jersey? These nine companies have open roles that could be a great fit for you.
Job listings in the area have ticked up in the last month. These seven companies are hiring in South San Francisco right now, including scientist and clinical roles.
Looking for a biopharma job in New York? Check out the BioSpace list of eight companies hiring life sciences professionals like you.
Career Advice
Clarity on employment terms is essential to protect careers. In this column, Kaye/Bassman’s Michael Pietrack speaks to employment attorney Howard Matalon, JD, partner at OlenderFeldman, on how to evaluate the fine print of an employment agreement.
THE LATEST
Gritstone Oncology is hanging a “help wanted” sign as the company looks to staff a new 43,000 square-foot manufacturing facility in Pleasanton, Calif. that will be the center of the company’s immunotherapy manufacturing efforts.
J&J is balking at a plan to build a site in Britain due to concerns over the economy.
Qiagen’s investment will be an expansion of its current operations in that northern England city.
The move is in part related to Brexit, the UK’s exit from the European Union.
Eli Lilly continues to make investments in its diabetes business.
Fresenius Kabi will invest $100M in eastern North Carolina as it expands its current production facility and prepares to build a new onsite manufacturing center.
Less than one week after the FDA cleared Innovative Health Solutions’ NSS-2 Bridge, the company announced it will expand its payroll to include a number of new businesses.
When complete, the expansion is expected to double the size of Regeneron’s footprint in Greenburgh.
The opportunity to work at the leading edge of science and technology while working on solutions to some of the world’s most vexing problems is what attracts people to Verily.
Investors love to speculate on M&A, and one of the hottest topics of speculation recently has been whether someone will buy BMS.